Novartis AG (NYSE:NVS)
| 90.95 Delayed Data As of 4:00pm ET |  -0.62 / -0.68%Today’s Change | 77.04 Today|||52-Week Range 98.52 | -3.69% Year-to-Date |
Latest NVS News | Press Releases
Today’s Trading
| Previous close | 91.57 |
| Today’s open | 91.08 |
| Day’s range | 90.78 - 91.29 |
| Volume | 1,141,409 |
| Average volume (3 months) | 1,796,149 |
| Market cap | $204.9B |
Data as of 4:00pm ET, 07/26/2021
Growth & Valuation
| Earnings growth (last year) | +15.91% |
| Earnings growth (this year) | +9.70% |
| Earnings growth (next 5 years) | +7.25% |
| Revenue growth (last year) | +2.95% |
| P/E ratio | 23.0 |
| Price/Sales | 4.43 |
| Price/Book | 3.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.41 | -0.35% |
| MRKMerck | -0.30 | -0.39% |
| AZNAstraZeneca | -1.44 | -2.47% |
| PFEPfizer | +0.13 | +0.31% |
Data as of 5:40pm ET, 07/26/2021
Financials
| Next reporting date | October 26, 2021 |
| EPS forecast (this quarter) | $1.62 |
| Annual revenue (last year) | $48.9B |
| Annual profit (last year) | $8.1B |
| Net profit margin | 16.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
